Patents by Inventor Cèline Steverlynck

Cèline Steverlynck has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Inhibitor of IRS-1 for treating skin disorders
    Patent number: 9359604
    Abstract: The present invention relates to an inhibitor of the expression of IRS-1 for treating an angiogenic and/or inflammatory skin disease. The present invention also relates to a transdermal composition, preferably an ointment, comprising an inhibitor of the expression of IRS-1, and to the use thereof for treating an angiogenic and/or inflammatory skin disease.
    Type: Grant
    Filed: July 3, 2012
    Date of Patent: June 7, 2016
    Assignee: GENE SIGNAL INTERNATIONAL SA
    Inventors: Salman Al-Mahmood, Sylvie Colin, Maud Bongaerts, Cèline Steverlynck, Jean-Pascal Conduzorgues, Amel Hadri, Eric Viaud
  • Inhibitor of IRS-1 for Treating Skin Disorders
    Publication number: 20140011858
    Abstract: The present invention relates to an inhibitor of the expression of IRS-1 for treating an angiogenic and/or inflammatory skin disease. The present invention also relates to a transdermal composition, preferably an ointment, comprising an inhibitor of the expression of IRS-1, and to the use thereof for treating an angiogenic and/or inflammatory skin disease.
    Type: Application
    Filed: July 3, 2012
    Publication date: January 9, 2014
    Inventors: Salman Al-Mahmood, Sylvie Colin, Maud Bongaerts, Cèline Steverlynck, Jean-Pascal Conduzorgues, Amel Hadri, Eric Viaud